Legis Daily

To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.

USA115th CongressHR-2889| House 
| Updated: 6/16/2017
Peter Welch

Peter Welch

Democratic Representative

Vermont

Cosponsors (3)
Gregg Harper (Republican)Collin C. Peterson (Democratic)Peter J. Visclosky (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Closing Loopholes for Orphan Drugs Act This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 13, 2017
Introduced in House
Jun 13, 2017
Referred to the House Committee on Energy and Commerce.
Jun 16, 2017
Referred to the Subcommittee on Health.
  • June 13, 2017
    Introduced in House
  • June 13, 2017
    Referred to the House Committee on Energy and Commerce.
  • June 16, 2017
    Referred to the Subcommittee on Health.

Health

Drug therapyHealth care costs and insuranceInflation and pricesPrescription drugs

To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.

USA115th CongressHR-2889| House 
| Updated: 6/16/2017
Closing Loopholes for Orphan Drugs Act This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 13, 2017
Introduced in House
Jun 13, 2017
Referred to the House Committee on Energy and Commerce.
Jun 16, 2017
Referred to the Subcommittee on Health.
  • June 13, 2017
    Introduced in House
  • June 13, 2017
    Referred to the House Committee on Energy and Commerce.
  • June 16, 2017
    Referred to the Subcommittee on Health.
Peter Welch

Peter Welch

Democratic Representative

Vermont

Cosponsors (3)
Gregg Harper (Republican)Collin C. Peterson (Democratic)Peter J. Visclosky (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug therapyHealth care costs and insuranceInflation and pricesPrescription drugs